MET and glioblastoma: Of note, MET and its ligand hepatocyte growth factor (HGF) also play critical roles in the proliferation, survival, migration, invasion, angiogenesis, stem cell characteristics, therapeutic resistance, and recurrence of glioblastomas (25–30).